INFLUENCE OF TRIPLICATE POLICY ON NARCOTIC UTILIZATION

因为它们有可能被患者和非患者滥用 同样，麻醉药品受到州和联邦政府的广泛监管 法律法规。尽管州政府和联邦政府 使用各种机制来控制药物使用和 乘务员费用、三份或多份处方复印件 (MCPP)，是一种越来越流行的策略，用于控制 零售层面的麻醉药品使用情况。尽管广泛存在 然而，对MCPP的采用没有充分的评估 它们的有效性，对医生处方模式的影响，以及 对病人护理的影响。这项研究的目的是检查 患者、医生和州监管机构的特征 可能会影响止痛药的使用。具体来说， 分析将强调MCPP对麻醉药品和 非麻醉性镇痛药的使用，同时考虑其影响 其他因素，即患者的社会人口学特征， 患者的健康状况，以及医师执业特点。 这项研究使用了1989年全国人口普查的横截面数据 门诊医疗护理调查(NAMCS)，对38,384个办公室的调查 就诊1876名医生。此外，NCHS还将纳入 描述处方的四个变量，包括MCPP状态 监管环境。使用Logistic回归和多项式回归 技术，这项研究将估计患者、医生和 预测止痛药使用的调节变量。这个 这项研究旨在回答四个问题：1)患者、医生、 以及导致止痛药的办公室探视的状态因素 与那些没有的不同？2)麻醉药物的模式是如何 MCPP州在办公室医疗实践中的使用情况不同 来自非MCPP状态？3)患者的特征是否具有 MCPP相关州对处方模式的不同影响 到非MCPP州？4)医生的特征是否有 MCPP相关州对处方模式的不同影响 到非MCPP州？为了应对不断上涨的药品成本和 处方药滥用和滥用问题，州和联邦 各国政府正在加强对处方药的审查 病人护理。因此，重要的是，政策制定者应该 了解旨在遏制毒品使用的计划以及 其他非计划特定因素，如患者和医生 特点，影响药品的分配和利用。 这项研究的发现将提供对这些问题的洞察 问题。

Due to their potential to be abused by patients and non-patients alike, narcotics are extensively regulated by state and federal laws and regulations. Although state and federal governments employ a variety of mechanisms to control drug utilization and attendant costs, triplicate, or Multiple Copy Prescription Programs (MCPPs), are an increasingly popular strategy used to control narcotic utilization at the retail level. Despite the widespread adoption of MCPPs, however, there has inadequate evaluation of their effectiveness, impact on physician prescribing patterns, and effect on patient care. The purpose of this study is to examine the patient, physician, and state regulatory characteristics which may influence the utilization of analgesic drugs. Specifically, the analysis will emphasize the impact of MCPPs on narcotic and non-narcotic analgesic utilization, while considering the influence of other factors, namely patient sociodemographic characteristics, patient health status, and physician practice characteristics. This study uses cross-sectional data from the 1989 National Ambulatory Medical Care Survey (NAMCS), a survey of 38,384 office visits to 1,876 physicians. In addition, NCHS will incorporate four variables, including MCPP status, describing the prescription regulatory environment. Using logistic and multinomial regression techniques, the study will estimate the patient, physician, and regulatory variables predicting analgesic drug utilization. The study aims to answer four questions: 1) How do patient, physician, and state factors for office visits resulting in an analgesic drug differ from those which do not? 2) How do patterns of narcotic utilization in office-based medical practice in MCPP states differ from non-MCPP states? 3) Do patient characteristics have a differential impact on prescribing patterns in MCPP states relative to non-MCPP states? 4) Do physician characteristics have a differential impact on prescribing patterns in MCPP states relative to non-MCPP states? In response to rising drug costs and the problem of prescription drug abuse and misuse, state and federal governments are increasing scrutiny of prescription drugs in patient care. It is important, therefore, for policy makers to understand how programs intended to curb drug use, as well as other, non-program specific factors such as patient and physician characteristics, affect the distribution and utilization of drugs. The findings from this study will provide insight into these issues.